Comparison of antifungal susceptibilities to fluconazole and voriconazole of oral Candida glabrata isolates from head and neck radiation patients

A. K. Burn, A. W. Fothergill, W. R. Kirkpatrick, B. J. Coco, T. F. Patterson, D. I. McCarthy, M. G. Rinaldi, S. W. Redding

Producción científica: Articlerevisión exhaustiva

10 Citas (Scopus)

Resumen

The antifungal susceptibilities of 79 oral Candida glabrata isolates to fluconazole and voriconazole were compared. The MICs at which 90% of the isolates tested were inhibited were 1 μg of voriconazole/ml and 32 μg of fluconazole/ml. Oral C. glabrata isolates for which the fluconazole MICs are elevated are commonly those for which the voriconazole MICs are elevated, but these increases may be transient for voriconazole, as they are for fluconazole.

Idioma originalEnglish (US)
Páginas (desde-hasta)5846-5848
Número de páginas3
PublicaciónJournal of clinical microbiology
Volumen42
N.º12
DOI
EstadoPublished - dic 2004

ASJC Scopus subject areas

  • Microbiology (medical)

Huella

Profundice en los temas de investigación de 'Comparison of antifungal susceptibilities to fluconazole and voriconazole of oral Candida glabrata isolates from head and neck radiation patients'. En conjunto forman una huella única.

Citar esto